Sun Pharma said it continues to manufacture and supply approved products from the facility to the US market. Previous Post Wobble in US AI stocks may benefit India, says Geosphere Capital’s Arvind Sanger Next Post Meesho shares fall 10% from highs after doubling from IPO price, hitting ₹1 lakh crore market cap Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email, and website in this browser for the next time I comment.Post Comment
